Vijaya Diagnostic Centre LimitedQ1 FY27 Results & Financial Update
Vijaya Diagnostic Centre Limited: Q1 FY27 consolidated results and company financials – revenue ₹230.98 Cr, PAT ₹53.10 Cr. Explore reported YoY/QoQ movements, margins, business drivers and management commentary. This page does not provide a rating, target price or investment recommendation.
Quarter at a glanceCurrent reported figures.Change figures appear when a comparable reported period is available.
Find an answer
Ask this result
Chart · Market context
Vijaya Diagnostic Centre price & chart
Market price₹1,368.20
1Y return—Price return
Loading market chart…
TradingView Lightweight Charts™ · Copyright © 2025 TradingView, Inc.TradingView
Market chartPrice chart temporarily unavailableThe price chart could not be loaded right now. The reported financial results remain available above.
Spotted a factual error?Tell us the number, date or statement and we will re-check the underlying records and calculations.Report an error
Quarterly Results AnalysisExplore Vijaya Diagnostic Centre Q1 FY27 quarterly results and earnings: revenue, profit (PAT), EBITDA, margins, YoY and QoQ growth, order book or business updates where reported, financial performance and management commentary. Reported figures and Nivata calculations are shown separately; no buy, sell or hold recommendation is provided.
Quarter overview
Quarterly earnings analysis
Vijaya Diagnostic Centre Limited reported consolidated revenue from operations of INR 230.98 crore for the quarter ended 30 June 2026 (Q1 FY27), accompanied by total income of INR 239.51 crore.
Profit before tax (PBT) for the quarter stood at INR 70.94 crore, while consolidated profit after tax (PAT) reached INR 53.10 crore, delivering a PAT margin of approximately 22.99%.
According to the company's earnings release, consolidated revenue grew by approximately 22.8% year-on-year, driven by a nearly 16.5% increase in test volumes, with absolute revenues surpassing Q4 FY26 despite Q1 typically representing a moderate season for the diagnostic industry.
Operational metrics detailed in company disclosures indicate total test volume of 4.59 million and total footfalls of 1.24 million for Q1 FY27, reflecting year-on-year growth rates of 16.5% and 12.7% respectively.
Average realization per test rose to INR 503 compared to INR 477 in the corresponding period of the previous year, while average realization per footfall increased to INR 1,860 from INR 1,707.
The company's PH (preventive healthcare / wellness) segment accounted for 14.8% of business during Q1 FY27, marking an increase of 56 basis points compared to the year-ago period.
Network expansion continued actively during the quarter, highlighted by the commissioning of four new spoke centres across Hyderabad, Andhra Pradesh, and Pune, alongside a major hub centre in Gachibowli, Hyderabad featuring a 160-slice cardiac CT.
01 · Business model
What does Vijaya Diagnostic Centre do?
Vijaya Diagnostic Centre Limited is one of India's leading integrated diagnostic chains, providing comprehensive diagnostic services spanning basic pathology to high-end radiology.
The company operates an extensive operational network consisting of over 160 diagnostic centres and 27 reference laboratories across 27 cities and towns spread throughout Telangana, Andhra Pradesh, Maharashtra, Karnataka, NCR, and West Bengal.
Revenue is generated through a balanced mix of pathology and radiology tests, serving individual walk-in patients as well as hospital networks, institutional clients, and wellness checkup participants.
The operating model relies on hub-and-spoke infrastructure combined with advanced medical equipment to capture both routine investigations and specialized high-end clinical imaging.
02 · Historical context
What shaped the business before this quarter
The company has previously integrated operations such as Medinova Diagnostic Services Limited and Medinova Millennium MRI Services LLP, expanding its service footprint through structured business transfers and amalgamations.
03 · Financial snapshot
Current-quarter financial snapshot
| Metric | Q1 FY27 |
|---|---|
| Revenue from operations | ₹230.98 Cr |
| Total income | ₹239.51 Cr |
| Profit before tax | ₹70.94 Cr |
| Profit after tax | ₹53.10 Cr |
| EPS | ₹5.15 |
Financial interpretation
What the reported numbers mean
Profit after tax represented 23.0% of reported quarterly operating revenue. This is a calculated net-profit-to-sales ratio, not a company-reported operating margin. It measures the outcome after expenses and tax; it does not, by itself, establish how margins changed versus another period.
Profit before tax was equivalent to 30.7% of quarterly operating revenue. The distinction between pre-tax and post-tax profit matters when interpreting earnings; neither ratio identifies an underlying cost driver without a properly matched comparative period.
Total income exceeded operating revenue by ₹8.53 crore. This is the disclosed difference between the two lines, not incremental sales. The distinction matters when assessing how much of the quarter’s reported income came from the operating top line.
Ratios above are calculated from the reported quarterly figures. They are analytical descriptions, not company-reported margin guidance or an investment recommendation.
04 · Why it moved
Why the quarter looked the way it did
What drove revenue
Total tests performed increased by 16.5% year-on-year to 4.59 million in Q1 FY27 from 3.94 million in Q1 FY26.
Total patient footfalls grew by 12.7% year-on-year to 1.24 million, supported by network additions across core geographies.
Average realization per test increased by 5.5% year-on-year to INR 503, and average realization per footfall rose by 9.0% to INR 1,860.
What drove margins
Cost of materials consumed was reported at INR 24.93 crore for the consolidated entity in Q1 FY27.
Employee benefit expenses stood at INR 33.83 crore for the quarter.
Other expenses accounted for INR 69.37 crore, reflecting overhead costs associated with expanded branch operations.
05 · Demand, customers & order book
Where demand is coming from
Wellness share of total business increased to 14.8% in Q1 FY27 compared to 14.2% in Q1 FY26.
06 · Segments, products & geography
Which parts of the business are doing the work
Segments and products
The company operates entirely within a single primary business segment, 'Diagnostic services', as reviewed by the Chief Operating Decision Maker.
Geography and market mix
The company expanded its operational footprint by commissioning four new spoke centres across Hyderabad, Andhra Pradesh, and Pune during Q1 FY27.
07 · Capacity, projects & execution
What is being built, commissioned or delivered
Capacity, production and utilisation
In April 2026, the company commissioned a new hub centre in Gachibowli, Hyderabad, equipped with a 160-slice cardiac CT scanner.
08 · Strategy & new businesses
How the company is trying to change its growth mix
Consolidated results incorporate subsidiaries including VDC Diagnostic (Karnataka) LLP, Medinova Millennium MRI Services LLP, and P H Diagnostic Centre Private Limited.
09 · Reported developments
What changed operationally
Consolidated revenue grew by approximately 22.8% year-on-year in Q1 FY27, outperforming seasonal trends.
10 · Cash flow & balance sheet
Profit is one thing. Cash and funding tell another part of the story.
Capital allocation & funding
Consolidated finance costs for Q1 FY27 were reported at INR 11.00 crore.
11 · Beyond the numbers
What changed beyond the numbers
Reported update
Stock option grants
During Q1 FY27, the company granted 179,500 employee stock options pursuant to the Employee Stock Option Plan 2018.
12 · Key Q&A
The quarter, answered directly
What does Vijaya Diagnostic Centre do?
Vijaya Diagnostic Centre Limited is one of India's leading integrated diagnostic chains, providing comprehensive diagnostic services spanning basic pathology to high-end radiology.
What is the clearest takeaway from Q1 FY27?
Vijaya Diagnostic Centre Limited reported consolidated revenue from operations of INR 230.98 crore for the quarter ended 30 June 2026 (Q1 FY27), accompanied by total income of INR 239.51 crore.
What drove revenue or demand?
Total tests performed increased by 16.5% year-on-year to 4.59 million in Q1 FY27 from 3.94 million in Q1 FY26.
What mattered most for margins or profitability?
Cost of materials consumed was reported at INR 24.93 crore for the consolidated entity in Q1 FY27.
What changed operationally beyond the headline numbers?
In April 2026, the company commissioned a new hub centre in Gachibowli, Hyderabad, equipped with a 160-slice cardiac CT scanner.
What should the next disclosure help confirm?
Monitor the formal completion and operational integration of the Arya Wellness Centre business transfer in Guwahati, Assam.
13 · Scenario calculator
Earnings sensitivity: what if growth and margins change?
Starting point
Build your own next-quarter scenario
Reported values are prefilled where a comparable basis is available. Otherwise, the field starts at 0. You can overwrite every field.
Example: enter 10 for 10% revenue growth. Enter -100 for a 1 percentage-point margin decline.
Scenario output
Scenario revenue / income₹0 cr
Scenario profit after tax₹0 cr
Profit change vs base₹0 cr (0%)
Scenario margin0%
Growth needed to keep profit flat after this margin move0%
The calculator holds the selected margin basis constant except for the basis-point adjustment you enter. It does not estimate tax, finance cost, dilution, working capital, valuation or share price.
14 · Next filing checkpoints
What the next disclosure can confirm or change
- 01
Post-period acquisition execution: Monitor the formal completion and operational integration of the Arya Wellness Centre business transfer in Guwahati, Assam.
Learn the metrics
Need the concepts first?
Use Nivata’s plain-English guides to understand the accounting terms used in this brief before interpreting them.